BioXcel Therapeutics, Inc.
NASDAQ:BTAI
1.87 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -59.599 | -179.053 | -165.757 | -106.931 | -82.169 | -32.968 | -19.27 | -4.539 | -2.12 | -0.636 |
| Depreciation & Amortization
| 0.309 | 0.318 | 0.327 | 0.297 | 0.188 | 0.156 | 0.017 | 0.001 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | -14.987 | -3.454 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 6.156 | 18.614 | 17.337 | 19.455 | 14.611 | 3.142 | 3.082 | 1.606 | 0.671 | 0 |
| Change In Working Capital
| -6.029 | 2.018 | 10.674 | 4.98 | 1.02 | 2.39 | 2.662 | 0.736 | 0.155 | 0.174 |
| Accounts Receivables
| -0.06 | 0.177 | -0.248 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 1.312 | -0.006 | -1.985 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -4.327 | -3.219 | 13.03 | 4.85 | 3.033 | 3.58 | 3.201 | 0.737 | 0.156 | 0 |
| Other Working Capital
| -2.954 | 5.066 | -0.123 | 0.13 | -2.013 | -1.19 | -0.539 | -0.001 | -0.001 | 0.174 |
| Other Non Cash Items
| -12.864 | 3.097 | 2.078 | 0.046 | 14.987 | 3.454 | 3.116 | 1.608 | 0.671 | 0.182 |
| Operating Cash Flow
| -72.027 | -155.006 | -135.341 | -82.153 | -66.35 | -27.28 | -13.509 | -2.196 | -1.294 | -0.28 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | -0.02 | -0.139 | -0.445 | -0.316 | -0.87 | -0.34 | 0 | -0.004 | -0.001 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | -0.87 | -0.34 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | -0.02 | -0.139 | -0.445 | -0.316 | -0.87 | -0.34 | 0 | -0.004 | -0.001 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -2.5 | 0 | 98.6 | 0 | 0 | 0 | -0.371 | 0.438 | 0 | 0 |
| Common Stock Issued
| 39.688 | 27.032 | 0 | 100.993 | 255.785 | 17.81 | 56.513 | 2.061 | 1.298 | 0.281 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -9.024 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.528 | -0.51 | -2.363 | 1.454 | 0.598 | 0.201 | -0.615 | 0.584 | 1.298 | 0.281 |
| Financing Cash Flow
| 36.66 | 26.522 | 96.237 | 102.447 | 247.359 | 18.011 | 55.527 | 3.083 | 1.298 | 0.281 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -35.367 | -128.504 | -39.243 | 19.849 | 180.693 | -10.139 | 41.678 | 0.887 | 0 | 0 |
| Cash At End Of Period
| 29.854 | 65.221 | 193.725 | 232.968 | 213.119 | 32.426 | 42.565 | 0.887 | 0 | 0 |